Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps2-20-03 | Thyroid hormone receptors basic | ETA2023

Epigenome-wide association study reveals cpg sites associated with thyroid function and regulatory effects on KLF9

Weihs Antoine , Chaker Layal , Martin Tiphaine , Bell Jordana , Medici Marco , Teumer Alexander

Thyroid hormones play a key role in cellular growth, development, and metabolism, and are known regulators of gene expression through genomic and non-genomic processes including DNA methylation. Using eight cohorts from the ThyroidOmics-Consortium and a standardized meta-analysis quality control pipeline, we conducted an epigenome-wide association study between blood-based leucocyte DNA methylation sites and thyroid hormones (TSH, free T3 and free T4) in up to 7,073 participan...

ea0099rc1.3 | Rapid Communications 1: Reproductive and Developmental Endocrinology | ECE2024

Clinical and genetic characterization of a large cohort of patients with premature ovarian failure

Federici Silvia , Messetti Dario , Rossetti Raffaella , Moleri Silvia , Persani Luca , Bonomi Marco

Primary ovarian insufficiency (POI) affects 1% of women before age 40 years, and in 70-90% of cases is defined as idiopathic. Although numerous POI-associated genes have been identified in recent years, the prevalence and pathogenicity of individual rare gene variants is still difficult to establish. The aim of our study was to retrospectively analyze the correlation between genotype and phenotype in patients with idiopathic POI, providing a more detailed characterization of P...

ea0099p269 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Study of genetic predisposition and other pathogenetic mechanisms underlying hypogonadotropic hypogonadism in type 2 diabetes mellitus

Cangiano Biagio , Amodeo Alessandro , Lunati Elena , Vezzoli Valeria , Galazzi Elena , Persani Luca , Fiorina Paolo , Bonomi Marco

Background: In patients affected by type 2 diabetes mellitus (T2DM) a high prevalence of hypogonadotropic hypogonadism (HH) has been reported, even if there is no consensus on its pathogenic mechanisms. In addition to acquired causes, an individual predisposition has also been suggested. The understanding ofPurpose: The aim of this observational study is to assess: (1) the prevalence of hypogonadism in T2DM using the validated criteria from the EMAS stud...

ea0099p525 | Pituitary and Neuroendocrinology | ECE2024

Pituitary apoplexy during the SARS-CoV-2 pandemic. role of acute covid-19 and covid vaccination

Valsecchi Fanny , Vassallo Alberto , Losa Marco , Frara Stefano , Mortini Pietro , Giustina Andrea

Background: Pituitary apoplexy (PA) is a rare endocrine and neurosurgical syndrome characterized by pituitary hemorrhage/infarction. SARS-CoV-2 infection and vaccination have been described as possible risk factors for PA, but the real impact of COVID-19 burden on PA epidemiology is still unknown.Purpose: To investigate the incidence of PA in the pandemic period during exposure to SARS-CoV-2 infection and vaccination and possible peculiar clinical charac...

ea0099ep741 | Adrenal and Cardiovascular Endocrinology | ECE2024

Clinical and biochemical data for the diagnosis of endogenous hypercortisolism: the “Cushingomic” approach

Ceccato Filippo , Bavaresco Alessandro , Ragazzi Eugenio , Barbot Mattia , Boscaro Marco , Basso Daniela , Carla Scaroni , Antonelli Giorgia

Background: The recommended first-line screening tests for Cushing’s syndrome (CS) are serum cortisol after 1-mg dexamethasone suppression test (FDST), urinary free cortisol (UFC), and late-night salivary cortisol (LNSC). CS is often diagnosed late: the clinical presentation of endogenous hypercortisolism overlaps with common clinical conditions.Methods: We analyzed the diagnostic test accuracy of FDST, UFC, and LNSC in patient...

ea0099ep219 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Non-alcoholic fatty liver disease. change from F3 to F1 fibrosis after 12 months of combined pioglitazone and dulaglutide treatment

Lener Luisa , Chianelli Marco , Graziano Filomena , Misischi Irene , Petrucci Lucilla , Rinaldi Roberta , Papini Enrico , Guglielmi Rinaldo

Background: Liver fibrosis is the result of the chronic hepatocyte damage due to different causes. Among them, Non-alcoholic Fatty Liver Disease (NAFLD) is estimated to account for nearly 30% of cases, representing a leading cause of chronic liver disease. NAFLD can evolve into non-alcoholic steatohepatitis, with or without fibrosis, whose diagnosis requires a liver biopsy, a costly and invasive procedure. Non-invasive tests have recently been proposed to screen patients at ri...

ea0101op-11-06 | Oral Session 11: Molecular Thyroidology | ETA2024

Unraveling the genetic landscape of hypothyroidism: insights from a multi-ancestry GWAS meta-analysis

Bujnis Melissa , Sterenborg Rosalie , Li Yong , Jorde Lynn , Medici Marco , Teumer Alexander

Autoimmune hypothyroidism, also known as Hashimoto’s thyroiditis (HT), is a common autoimmune thyroid disorder with a prevalence of 3-5% in the United States and Europe. Despite its high prevalence and high heritability (~70%), very little is known about the genetic basis of autoimmune hypothyroidism. To improve our understanding of the genetic signatures associated with HT development, we conducted a genome-wide association studies (GWAS) and follow-up analyses using ten...

ea0101ps1-07-04 | Case reports | ETA2024

Combined immune checkpoint inhibitor therapy and onset of graves’ hyperthyroidism followed by seroconversion to autoimmune hypothyroidism: a case report

Juul Thomsen Marco , Linding Andersen Stine , Maria Uldall Torp Nanna , Andersen Stig , Carle Allan

Introduction: Immune checkpoint inhibitors are used as therapy for advanced malignancies. The therapy is based on immune enhancement, thus, autoimmune side effects referred to as immune-related adverse events may occur. Thyroid function abnormalities have been reported, but more evidence is needed to substantiate the main subtypes and course of thyroid disease associated with this treatment.Case report: A 51-year-old woman with metastatic pancreatic canc...

ea0101ps3-25-02 | Hypothyroidism | ETA2024

A national randomized placebo-controlled double-blind multicenter trial of LT4/lT3 combination therapy in patients with autoimmune hypothyroidism: T3-4-hypo trial

Blankers Lizette , Peeters Robin , Boelen Anita , Edward Visser W. , Medici Marco

Despite normalized serum thyroid hormone levels, 10% of hypothyroid patients treated with levothyroxine (LT4) have persistent complaints, of which tiredness is the most commonly reported. This could be explained by the fact that the physiological T4/T3 ratio is not achieved with LT4 monotherapy. Studies have reported contradicting results as to whether the addition of liothyronine (LT3) is effective in relieving these persistent complaints. However, all of these studies suffer...

ea0063p1034 | Interdisciplinary Endocrinology 2 | ECE2019

Harmonization status among ten European laboratories using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for steroid measurements in serum: preliminary results from the HarmoSter consortium

Fanelli Flaminia , Mezzullo Marco , Temchenko Anastasia , Cantu Marco , Lindner Johanna M , Peitzsch Mirko , Hawley James M , Bruce Stephen , Zelzer Sieglinde , Herrmann Markus , Heijboer Annemieke C , Van den Ouweland Jody , Eisenhofer Graeme , Keevil Brian G , Rauh Manfred , Vogeser Michael , Pagotto Uberto

Background: LC-MS/MS is replacing immunoassays for serum steroid measurement in clinical labs worldwide. The intrinsic high specificity of LC-MS/MS is supposed to guarantee accurate quantitation, however, differences in pre-analytical and analytical procedures, and overall performance may influence the result. A few studies so far investigated the reproducibility among different LC-MS/MS assays for sex steroids. No data are available for adrenal steroids.<p class="abstext"...